Compounds > zm 230487
Page last updated: 2024-09-04

zm 230487 and leukotriene b4

zm 230487 has been researched along with leukotriene b4 in 4 studies

Compound Research Comparison

Studies
(zm 230487)		Trials
(zm 230487)		Recent Studies (post-2010)
(zm 230487)		Studies
(leukotriene b4)		Trials
(leukotriene b4)		Recent Studies (post-2010) (leukotriene b4)
17005,886232717

Protein Interaction Comparison

ProteinTaxonomyzm 230487 (IC50)leukotriene b4 (IC50)
Leukotriene B4 receptor 1Homo sapiens (human)0.0019

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hellewell, PG; Teixeira, MM1
Hellewell, PG; Macari, DM; Teixeira, MM1
Giembycz, MA; Hellewell, PG; Lindsay, MA; Teixeira, MM1
Alcaraz, MJ; Guillén, MI; Vicente, AM1

Other Studies

4 other study(ies) available for zm 230487 and leukotriene b4

ArticleYear
Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.
    British journal of pharmacology, 1994, Volume: 111, Issue:4

    Topics: Animals; Arachidonic Acid; Edema; Eosinophils; Guinea Pigs; Leukotriene B4; Lipoxygenase Inhibitors; Male; Passive Cutaneous Anaphylaxis; Pyrans; Quinolones

1994
Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Aug-15, Volume: 157, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan

1996
Role of arachidonic acid in leukotriene B(4)-induced guinea-pig eosinophil homotypic aggregation.
    European journal of pharmacology, 1999, Nov-19, Volume: 384, Issue:2-3

    Topics: Animals; Arachidonic Acid; Calcium; Cell Aggregation; Dose-Response Relationship, Drug; Eosinophils; Female; Guinea Pigs; Leukotriene Antagonists; Leukotriene B4; Lipoxygenase Inhibitors; Male; Phospholipases A; Pyrans; Quinacrine; Quinolones; Tetradecanoylphorbol Acetate; Tetrazoles

1999
Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.
    British journal of pharmacology, 2001, Volume: 133, Issue:6

    Topics: Amidines; Animals; Benzylamines; Cell Line; Chick Embryo; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxyurea; Indomethacin; Isoenzymes; Leukotriene B4; Leukotriene C4; Leukotrienes; Macrophage Activation; Macrophages; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrans; Quinolones; Sulfonamides; Time Factors; Transcription Factor AP-1; Zymosan

2001